BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26261577)

  • 1. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
    Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
    Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of primary aldosteronism and separation of two major subtypes.
    Weinberger MH; Fineberg NS
    Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conn's adenoma. Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio].
    Massien-Simon C; Battaglia C; Chatellier G; Guyene TT; Duclos JM; Plouin PF
    Presse Med; 1995 Sep; 24(27):1238-42. PubMed ID: 7501604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.
    Loh KC; Koay ES; Khaw MC; Emmanuel SC; Young WF
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2854-9. PubMed ID: 10946893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose captopril as a diagnostic test for primary aldosteronism.
    Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
    J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism.
    Ignatowska-Switalska H; Chodakowska J; Januszewicz W; Feltynowski T; Adamczyk M; Lewandowski J
    J Hum Hypertens; 1997 Jun; 11(6):373-8. PubMed ID: 9249232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of the post-captopril test in primary aldosteronism.
    Castro OL; Yu X; Kem DC
    Hypertension; 2002 Apr; 39(4):935-8. PubMed ID: 11967253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.
    Gallay BJ; Ahmad S; Xu L; Toivola B; Davidson RC
    Am J Kidney Dis; 2001 Apr; 37(4):699-705. PubMed ID: 11273868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient screening tests for primary aldosteronism.
    Dunn PJ; Espiner EA
    Aust N Z J Med; 1976 Apr; 6(2):131-5. PubMed ID: 1067811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature.
    Montori VM; Young WF
    Endocrinol Metab Clin North Am; 2002 Sep; 31(3):619-32, xi. PubMed ID: 12227124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone to renin ratios in the evaluation of primary aldosteronism.
    Eng PH; Tan KE; Khoo DH; Tan CE; Lim HS; Lim SC; Koh LK; Ho SC; Tai ES; Fok AC
    Ann Acad Med Singap; 1997 Nov; 26(6):762-6. PubMed ID: 9522976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study.
    Tezuka Y; Omata K; Ono Y; Kambara K; Kamada H; Oguro S; Yamazaki Y; Gomez-Sanchez CE; Ito A; Sasano H; Takase K; Tanaka T; Katagiri H; Satoh F
    Hypertens Res; 2024 May; 47(5):1362-1371. PubMed ID: 38454147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism.
    Lins PE; Adamson U
    Acta Endocrinol (Copenh); 1986 Dec; 113(4):564-9. PubMed ID: 3538743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?
    Hamlet SM; Tunny TJ; Woodland E; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):249-52. PubMed ID: 3896593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA).
    Lin CH; Lin CH; Chung MC; Hung CS; Tseng FY; Er LK; Jia-Yin Hou C; Lin YH; Wu VC; Cheng HM; Kao HL; Wu KD; Lai TS
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S98-S103. PubMed ID: 37173226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.